These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Lung dendritic cells: targets for therapy in allergic disease. Lambrecht BN; Hammad H Handb Exp Pharmacol; 2009; (188):99-114. PubMed ID: 19031023 [TBL] [Abstract][Full Text] [Related]
6. Aryl hydrocarbon receptor activation inhibits in vitro differentiation of human monocytes and Langerhans dendritic cells. Platzer B; Richter S; Kneidinger D; Waltenberger D; Woisetschläger M; Strobl H J Immunol; 2009 Jul; 183(1):66-74. PubMed ID: 19535631 [TBL] [Abstract][Full Text] [Related]
7. Activating and inhibitory signaling in mast cells: new opportunities for therapeutic intervention? Ott VL; Cambier JC J Allergy Clin Immunol; 2000 Sep; 106(3):429-40. PubMed ID: 10984360 [TBL] [Abstract][Full Text] [Related]
8. Imbalance of NKG2D and its inhibitory counterparts: how does tumor escape from innate immunity? Zhang C; Zhang J; Wei H; Tian Z Int Immunopharmacol; 2005 Jul; 5(7-8):1099-111. PubMed ID: 15914316 [TBL] [Abstract][Full Text] [Related]
10. TREM2-transduced myeloid precursors mediate nervous tissue debris clearance and facilitate recovery in an animal model of multiple sclerosis. Takahashi K; Prinz M; Stagi M; Chechneva O; Neumann H PLoS Med; 2007 Apr; 4(4):e124. PubMed ID: 17425404 [TBL] [Abstract][Full Text] [Related]
11. Structure/function relationship of activating Ly-49D and inhibitory Ly-49G2 NK receptors. Ortaldo JR; Winkler-Pickett R; Willette-Brown J; Wange RL; Anderson SK; Palumbo GJ; Mason LH; McVicar DW J Immunol; 1999 Nov; 163(10):5269-77. PubMed ID: 10553049 [TBL] [Abstract][Full Text] [Related]
12. Collagen-mediated survival signaling is modulated by CD45 in Jurkat T cells. Bijian K; Zhang L; Shen SH Mol Immunol; 2007 Jul; 44(15):3682-90. PubMed ID: 17524482 [TBL] [Abstract][Full Text] [Related]
13. Allergy, Allergic Inflammation and Asthma--Keystone Symposium. Pharmacological targets in allergic inflammation and asthma. Kierstein S IDrugs; 2006 Jun; 9(6):405-8. PubMed ID: 16752308 [No Abstract] [Full Text] [Related]
14. Interleukin 1 and tumor necrosis factor signal transduction mechanisms: potential targets for pharmacological control of inflammation. Saklatvala J; Guesdon F J Rheumatol Suppl; 1992 Jan; 32():65-9; discussion 69-70. PubMed ID: 1319489 [TBL] [Abstract][Full Text] [Related]
15. TREM-1 (triggering receptor expressed on myeloid cells): a new player in acute inflammatory responses. Colonna M; Facchetti F J Infect Dis; 2003 Jun; 187 Suppl 2():S397-401. PubMed ID: 12792857 [TBL] [Abstract][Full Text] [Related]
16. Intracellular signaling by the killer immunoglobulin-like receptors and Ly49. McVicar DW; Burshtyn DN Sci STKE; 2001 Mar; 2001(75):re1. PubMed ID: 11752646 [TBL] [Abstract][Full Text] [Related]